US Patent 11679132 Methods for enhancing efficacy of therapeutic immune cells
Patent 11679132 was granted and assigned to National University of Singapore on June, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 4 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 21 Jun, 2023
Golden AI
Edits made to:
Infobox (+24 properties)
Article (+442 characters)
US Patent 11679132 Methods for enhancing efficacy of therapeutic immune cells
Article
The present invention relates to a method of using a receptor (e.g., chimeric antigen receptor—CAR) that activates an immune response upon binding a cancer cell ligand in conjunction with a target-binding molecule that targets a protein or molecule for removal or neutralization to generate enhanced anti-cancer immune cells. The present invention also relates to engineered immune cells having enhanced therapeutic efficacy and uses thereof.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
116791320
Date of Patent
June 20, 2023
0Patent Application Number
178627210
Date Filed
July 12, 2022
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11679132 Methods for enhancing efficacy of therapeutic immune cells
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
